Would you consider adjuvant radiation for a patient with recurrent pelvic node melanoma s/p immunotherapy and pelvic lymph node dissection with complete pathological response (only necrotic tissue; no viable melanoma)?
1 Answers
Mednet Member
Radiation Oncology · Memorial Sloan Kettering Cancer Center
At this point, no. These patients seem to have a low risk of recurrence if they experience pathologic complete response following neoadjuvant immunotherapy.
Would you consider adjuvant radiation for a patient with recurrent pelvic node melanoma s/p immunotherapy and pelvic lymph node dissection with complete pathological response (only necrotic tissue; no viable melanoma)? | Mednet
